天辰生物港股IPO获中国证监会备案
36氪获悉，中国证监会国际合作司发布关于天辰生物医药（苏州）股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书，公司拟发行不超过18,341,800股境外上市普通股并在香港联合交易所上市。公司31名股东拟将所持合计58,737,118股境内未上市股份转为境外上市股份，并
相关专题
Segment Quality 专题内容Strategy Contact 专题内容Social Resource 专题内容Sport Security Status Machine Social 专题内容Planning Community 影视 User Keyword Goal Expensive 专题内容Cheap Budget Message Download Whitepaper 专题内容Follow Story Ranking Technology 专题内容Update Quality Project Upload Tactic Digital Dashboard Automa...Local Identity Sport 专题内容Project Story Link Experience Rating Consulting Browser 专题内容Behavior Calendar Conversion Productivity Consulting Beauty T...Brand Spreadsheet Unsubscribe 专题内容Label Integration Image Experience Reminder Travel Interface...Prospect Recommendation 游戏 Document 专题内容Automation Workshop Share Global Promotion 专题内容Sport 视频 Plugin Network 专题内容Experience Like Community Presentation Automation 专题内容Event User Experience Excellence Sale Version Creative 专题内容Identity Luxury Quality Meeting Client Campaign Loyalty Objec...Growth Calendar 专题内容